Epizyme CEO Bazemore: Cancer Survivor Brings Patient Perspective

Epizyme Inc. president and CEO Robert Bazemore's first thought when he was diagnosed with Stage 4 diffuse large B-cell lymphoma (DLBCL) – an advanced form of non-Hodgkin lymphoma (NHL) with a 50-50 chance of survival – was that his young children wouldn't remember him when he was gone.